Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update

Go back to Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
(NYSE: NSRX) Delayed: 3.53 --0 (-0%)
Previous Close $3.53    52 Week High
Open $3.35    52 Week Low
Day High $3.58    P/E N/A 
Day Low $3.35    EPS
Volume 12,021